Takeda’s Agreement with Adium Pharma

Ambrogio Visconti
Tagged:

Marval O’Farrell Mairal advised Takeda on the transactionTakeda Pharmaceutical Company Limited  (TSE:4502/NYSE:TAK) has entered into an agreement to divest a selection of non-core products from the Company’s…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now